4.4 Article

Risk of Long COVID in People Infected With Severe Acute Respiratory Syndrome Coronavirus 2 After 2 Doses of a Coronavirus Disease 2019 Vaccine: Community-Based, Matched Cohort Study

Related references

Note: Only part of the references are listed.
Article Infectious Diseases

Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study

Michela Antonelli et al.

Summary: Despite the high efficacy of COVID-19 vaccines, some individuals still become infected with SARS-CoV-2 post-vaccination. Risk factors for post-vaccination infection include frailty in older adults, living in deprived areas, and obesity. Vaccination is associated with reduced odds of severe symptoms and long-duration illness. The findings suggest the importance of targeting at-risk populations and maintaining infection control measures even in vaccinated individuals.

LANCET INFECTIOUS DISEASES (2022)

Article Immunology

Six-month sequelae of post-vaccination SARS-CoV-2 infection: A retrospective cohort study of 10,024 breakthrough infections

Maxime Taquet et al.

Summary: Vaccination against COVID-19 has been shown to reduce the risk of certain outcomes following SARS-CoV-2 infection, but not all outcomes. The age and number of vaccine doses may have an impact on the effectiveness of the vaccine.

BRAIN BEHAVIOR AND IMMUNITY (2022)

Article Multidisciplinary Sciences

Long COVID burden and risk factors in 10 UK longitudinal studies and electronic health records

Ellen J. Thompson et al.

Summary: The frequency and risk factors of long COVID in community-based individuals are unclear. A study analyzing data from 10 UK population-based studies and electronic health records found wide variation in the frequency of long COVID between studies, but identified some consistent risk factors.

NATURE COMMUNICATIONS (2022)

Article Primary Health Care

Clinical coding of long COVID in English primary care: a federated analysis of 58 million patient records in situ using OpenSAFELY

Alex J. Walker et al.

Summary: Recording of long COVID in primary care in England is low and shows significant variation between practices. Possible factors contributing to this include lack of patient presentation, differing diagnostic thresholds among clinicians and patients, and challenges with the design and communication of diagnostic codes. It is recommended to increase awareness of diagnostic codes to support research and service planning, and to conduct qualitative surveys to better understand clinicians' perspectives on diagnosis.

BRITISH JOURNAL OF GENERAL PRACTICE (2021)

Article Biochemistry & Molecular Biology

Impact of vaccination on new SARS-CoV-2 infections in the United Kingdom

Emma Pritchard et al.

Summary: Results from the Office for National Statistics COVID-19 Infection Survey in the UK demonstrate that the ChAdOx1 nCoV-19 and BNT162b2 vaccines reduce the incidence of new SARS-CoV-2 infections by up to 65% with a single dose and up to 80% after two doses, with no significant differences in efficacy observed between the two vaccines.

NATURE MEDICINE (2021)

Article Medicine, General & Internal

Characterizing long COVID in an international cohort: 7 months of symptoms and their impact

Hannah E. Davis et al.

Summary: Patients with Long COVID report prolonged, multisystem involvement and significant disability. By seven months, many patients have not yet recovered (mainly from systemic and neurological/cognitive symptoms), have not returned to previous levels of work, and continue to experience significant symptom burden.

ECLINICALMEDICINE (2021)